QUANTITATIVE ANALYSIS OF THE EXPRESSION OF DOPAMINE D-1 AND D-2 RECEPTORS IN PYRAMIDAL AND GABAERGIC NEURONS OF THE RAT PREFRONTAL CORTEX
El splicing alternativo de H-Ras en mamíferos une varios factores de splicing a procesos cancerígenos.
Tissue plasminogen activator induces pancreas cancer cell proliferation by a non-catalytic mechanism that requires ERK1/2 activation through Epidermal Growth Factor Receptor and Annexin A2
"UPREGULATION OF CCAAT/ENHANCER BINDING PROTEIN BETA IN ACTIVATED ASTROCYTES AND MICROGLIA."
''DISTRIBUTION OF CLOSTRIDIUM PERFRINGENS EPSILON TOXIN IN THE BRAINS OF ACUTELY INTOXICATED MICE AND ITS EFFECT PON GLIAL CELLS.''
''CCAAT/ENHANCER BINDING PROTEIN ALPHA IS DOWNREGULATED BY TOLL-LIKE RECEPTOR AGONISTS IN MICROGLIAL CELLS.''
Trimethylguanosine nucleoside inhibits cross-linking between Snurportin 1 and m3G-capped U1 snRNP
Tissue plasminogen activator mediates amyloid induced neurotoxicity via sustained Erk1/2 activation.
The tissue plasminogen activator system in murine exocrine pancreas cancer:selective expression in ductal tumors and contribution to cancer progression.
New insights into the tPA-Annexin A2 interaction: is Annexin A2 Cys8 the sole requirement for this association?
Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein which trafficks to cytoplasm and nucleus.
HnRNP A1 and SR proteins regulate the alternative splicing of proto-oncogen c-H-ras, balancing the relative abundance of two alternative H-Ras proteins, p19 and p21.
Study of the 2719 mutant of the c-H-ras oncogen in a bi-intronic alternative splicing system.
Modulation in vitro of H-ras oncogene expresión by trans-splicing
Post-transcriptional regulation of rat carnitine octanoyltransferase.
Localization of an exonic splicing enhancer responsible for mammalian natural trans-splicing
Alternative splicing of c-H-ras, a system to study different aspects of the splicing mechanism.
Processing of carnitine octanoyltransferase pre-mRNAs by cis and trans-splicing.
